| 1 | Gastrinoma | 45.1% |
| 2 | Glucagonoma | 45.1% |
| 3 | Carcinoma, Pancreatic Ductal | 35.9% |
| 4 | Peritoneal Neoplasms | 23.5% |
| 5 | insulinoma | 23.2% |
| 6 | Multiple Endocrine Neoplasia | 21.9% |
| 7 | Parathyroid Neoplasms | 20.6% |
| 8 | Thyroid Neoplasm | 20.6% |
| 9 | Thyroid carcinoma | 20.6% |
| 10 | Neoplasms, Neuroepithelial | 20.4% |
| 11 | Gliomatosis cerebri | 20.4% |
| 12 | Carcinoid Tumor | 19.6% |
| 13 | Gastrointestinal Neoplasms | 19.5% |
| 14 | Liver neoplasms | 19.5% |
| 15 | Carcinoma, Lobular | 18.2% |
| 16 | melanoma | 16.8% |
| 17 | Esophageal Neoplasms | 16.5% |
| 18 | Adrenal Gland Neoplasms | 16.2% |
| 19 | Adenoma, Acidophil | 15.8% |
| 20 | Carcinoma, Ehrlich Tumor | 15.4% |
| 21 | Carcinoma, Lewis Lung | 15.4% |
| 22 | Choriocarcinoma | 15.3% |
| 23 | Cystadenocarcinoma | 15.2% |
| 24 | Mucoepidermoid Carcinoma | 15.2% |
| 25 | Hepatocellular Adenoma | 14.9% |
| 26 | Testicular Neoplasms | 14.8% |
| 27 | Trophoblastic Neoplasms | 14.6% |
| 28 | Basal cell carcinoma | 14.6% |
| 29 | Carcinoma, Papillary | 14.6% |
| 30 | Squamous cell carcinoma | 14.6% |
| 31 | Carcinoma, Basal Cell | 14.6% |
| 32 | Liver Neoplasms, Experimental | 14.3% |
| 33 | Abdominal Neoplasms | 14.3% |
| 34 | Head and Neck Neoplasms | 14.3% |
| 35 | Soft Tissue Neoplasms | 14.3% |
| 36 | Thoracic Neoplasms | 14.3% |
| 37 | leukemia | 13.9% |
| 38 | Hamartoma | 13.8% |
| 39 | Neoplasms, Hormone-Dependent | 13.8% |
| 40 | Neoplasms, Multiple Primary | 13.8% |
| 41 | Paraneoplastic Syndromes | 13.8% |
| 42 | Precancerous Conditions | 13.8% |
| 43 | Neoplasms, Second Primary | 13.8% |
| 44 | Melanoma, Experimental | 13.7% |
| 45 | Pancreatic Cyst | 13.6% |
| 46 | Carcinoma, Ovarian Epithelial | 13.3% |
| 47 | Malignant Carcinoid Syndrome | 13.2% |
| 48 | Eye Neoplasms | 13.1% |
| 49 | Nervous System Neoplasms | 13.1% |
| 50 | Adrenocortical carcinoma | 13% |
| 51 | Meningioma | 13% |
| 52 | Neurilemmoma | 12.9% |
| 53 | Bone neoplasms | 12.9% |
| 54 | Skin Neoplasms | 12.9% |
| 55 | Hematologic Neoplasms | 12.9% |
| 56 | ovarian neoplasm | 12.8% |
| 57 | Splenic Neoplasms | 12.8% |
| 58 | Craniopharyngioma | 12.8% |
| 59 | Neuroectodermal Tumor, Melanotic | 12.8% |
| 60 | Acanthoma | 12.5% |
| 61 | Histiocytic Disorders, Malignant | 12.4% |
| 62 | Cyst | 12.3% |
| 63 | Neoplastic Processes | 12.3% |
| 64 | Neoplastic Syndromes, Hereditary | 12.3% |
| 65 | Pregnancy Complications, Neoplastic | 12.3% |
| 66 | Neoplasms, Experimental | 12.2% |
| 67 | Multiple Endocrine Neoplasia Type 1 | 12.2% |
| 68 | Bile Duct Neoplasms | 12.2% |
| 69 | gallbladder neoplasm | 12.2% |
| 70 | Intestinal Neoplasms | 12.2% |
| 71 | Stomach Neoplasms | 12.2% |
| 72 | Paraneoplastic Encephalomyelitis | 12.1% |
| 73 | Prolactinoma | 12.1% |
| 74 | Growth Hormone-Secreting Pituitary Adenoma | 12.1% |
| 75 | Paraganglioma | 12% |
| 76 | Thyroid Nodule | 12% |
| 77 | Mammary Neoplasms, Experimental | 12% |
| 78 | Medulloblastoma | 12% |
| 79 | Ganglioneuroma | 12% |
| 80 | Glioma | 12% |
| 81 | Malignant Glioma | 12% |
| 82 | Dermoid Cyst | 11.8% |
| 83 | Leukemia, Experimental | 11.7% |
| 84 | Pituitary Adenoma | 11.6% |
| 85 | Pituitary Neoplasms | 11.6% |
| 86 | Digestive System Neoplasms | 11.4% |
| 87 | Retinoblastoma | 11.3% |
| 88 | Lymphoma | 11.2% |
| 89 | Carcinoma 256, Walker | 11.1% |
| 90 | Neoplasms, Radiation-Induced | 11.1% |
| 91 | Adenoma | 11% |
| 92 | Chordoma | 11% |
| 93 | Teratoma | 11% |
| 94 | Germinoma | 11% |
| 95 | Teratocarcinoma | 11% |
| 96 | Cystadenoma | 11% |
| 97 | Mesothelioma | 11% |
| 98 | Adenoid Cystic Carcinoma | 11% |
| 99 | Adenocarcinoma, Clear Cell | 11% |
| 100 | Cholangiocarcinoma | 11% |
| 101 | Adenomatous Polyposis Coli | 10.9% |
| 102 | Tuberous Sclerosis | 10.8% |
| 103 | Composite Lymphoma | 10.8% |
| 104 | Neuroectodermal Tumors | 10.8% |
| 105 | Zollinger-Ellison syndrome | 10.8% |
| 106 | Leukemia, Radiation-Induced | 10.7% |
| 107 | Hutchinson's Melanotic Freckle | 10.7% |
| 108 | Melanoma, Amelanotic | 10.7% |
| 109 | Carcinosarcoma | 10.3% |
| 110 | Hemangiosarcoma | 10.3% |
| 111 | lymphangiosarcoma | 10.3% |
| 112 | Carcinoma in Situ | 10.2% |
| 113 | Carcinoma, Transitional Cell | 10.2% |
| 114 | Carcinoma, Large Cell | 10.2% |
| 115 | Carcinoma, Small Cell | 10.2% |
| 116 | Choledochal Cyst | 10% |
| 117 | Pancreatic Fistula | 9.8% |
| 118 | Thymoma | 9.7% |
| 119 | granulosa cell tumor | 9.6% |
| 120 | Nephroblastoma | 9.4% |
| 121 | Acoustic Neuroma | 9.4% |
| 122 | Pancreatic Neoplasm | 9.4% |
| 123 | Basal Cell Nevus Syndrome | 9.3% |
| 124 | Leukemia, Plasma Cell | 9.3% |
| 125 | Tracheal Neoplasms | 9.2% |
| 126 | Carcinoid Heart Disease | 9.2% |
| 127 | Gastrointestinal Stromal Tumors | 9.2% |
| 128 | Sarcoma, Experimental | 9% |
| 129 | Bowen's Disease | 8.8% |
| 130 | Neoplasms, Germ Cell and Embryonal | 8.8% |
| 131 | Neoplasms, Glandular and Epithelial | 8.8% |
| 132 | Germ Cell Cancer | 8.8% |
| 133 | Colorectal Neoplasms | 8.7% |
| 134 | Renal Cell Carcinoma | 8.6% |
| 135 | Papillary Renal Cell Carcinoma | 8.6% |
| 136 | Carcinoma, Endometrioid | 8.6% |
| 137 | Barrett Esophagus | 8.5% |
| 138 | Cecal Neoplasms | 8.4% |
| 139 | Duodenal Neoplasms | 8.4% |
| 140 | Pheochromocytoma | 8.1% |
| 141 | Endocrine Gland Neoplasms | 8.1% |
| 142 | Pancreatic Insufficiency | 8.1% |
| 143 | Pancreatitis | 8.1% |
| 144 | Retroperitoneal Neoplasms | 7.8% |
| 145 | Astrocytoma | 7.8% |
| 146 | Ependymoma | 7.8% |
| 147 | oligodendroglioma | 7.8% |
| 148 | Ganglioglioma | 7.8% |
| 149 | gliosarcoma | 7.8% |
| 150 | Anaplastic astrocytoma | 7.8% |
| 151 | Anaplastic Oligodendroglioma | 7.8% |
| 152 | Pancreatic Pseudocyst | 7.7% |
| 153 | Chondrosarcoma | 7.5% |
| 154 | leiomyosarcoma | 7.5% |
| 155 | liposarcoma | 7.5% |
| 156 | synovial sarcoma | 7.5% |
| 157 | Angiomyolipoma | 7.5% |
| 158 | Clear Cell Sarcoma of Soft Tissue | 7.5% |
| 159 | Alveolar Soft Part Sarcoma | 7.5% |
| 160 | Sarcoma, Myeloid | 7.5% |
| 161 | Ameloblastoma | 7.4% |
| 162 | Angiokeratoma | 7.4% |
| 163 | Hemangioma | 7.4% |
| 164 | hemangiopericytoma | 7.4% |
| 165 | Lymphangioma | 7.4% |
| 166 | Mesenchymoma | 7.4% |
| 167 | Nevus | 7.4% |
| 168 | Hepatoblastoma | 7.4% |
| 169 | Mixed Tumor, Mullerian | 7.4% |
| 170 | Angiofibroma | 7.4% |
| 171 | Sarcoma | 7.4% |
| 172 | Biliary Tract Diseases | 7.4% |
| 173 | Gastrointestinal Diseases | 7.4% |
| 174 | Liver diseases | 7.4% |
| 175 | Klatskin Tumor | 7.4% |
| 176 | Endometrial Stromal Sarcoma | 7.3% |
| 177 | Leukemia L1210 | 7.1% |
| 178 | Leukemia P388 | 7.1% |
| 179 | Nasopharyngeal carcinoma | 7.1% |
| 180 | Adenofibroma | 7.1% |
| 181 | Fibroadenoma | 7.1% |
| 182 | Erythroplasia | 7.1% |
| 183 | Follicular cyst | 7.1% |
| 184 | Mucocele | 7.1% |
| 185 | Pilonidal Cyst | 7.1% |
| 186 | Thyroglossal Cyst | 7.1% |
| 187 | Synovial Cyst | 7.1% |
| 188 | Aberrant Crypt Foci | 7.1% |
| 189 | Leydig Cell Tumor | 7% |
| 190 | Optic Nerve Glioma | 7% |
| 191 | Mouth Neoplasms | 7% |
| 192 | Central Nervous System Neoplasms | 7% |
| 193 | Vascular Neoplasms | 7% |
| 194 | Thymus Neoplasms | 7% |
| 195 | Lymphomatoid Granulomatosis | 7% |
| 196 | Genital Neoplasms, Female | 7% |
| 197 | Breast Neoplasms, Male | 7% |
| 198 | Triple Negative Breast Neoplasms | 7% |
| 199 | Corpus Luteum Cyst | 6.6% |
| 200 | Ovarian Cysts | 6.6% |
| 201 | Plasmacytoma | 6.6% |
| 202 | Malignant histiocytosis | 6.6% |
| 203 | Histiocytic sarcoma | 6.6% |
| 204 | Mesoblastic Nephroma | 6.4% |
| 205 | Genital Neoplasms, Male | 6.4% |
| 206 | Uveal Neoplasms | 6.4% |
| 207 | Leukoplakia | 6.4% |
| 208 | Lymphocele | 6.4% |
| 209 | Urologic Neoplasms | 6.3% |
| 210 | Peutz-Jeghers Syndrome | 6.3% |
| 211 | Breast Cyst | 6.3% |
| 212 | Actinic keratosis | 6.3% |
| 213 | Mediastinal Cyst | 6.3% |
| 214 | Neoplasm Invasiveness | 6.3% |
| 215 | Neoplasm Metastasis | 6.3% |
| 216 | Neoplasm Recurrence, Local | 6.3% |
| 217 | Parovarian Cyst | 6.3% |
| 218 | Pericardial Cyst | 6.3% |
| 219 | Thymic Cyst | 6.3% |
| 220 | Carcinogenesis | 6.3% |
| 221 | Myxoid cyst | 6.3% |
| 222 | Metastasis | 6.3% |
| 223 | Sebaceous Gland Neoplasms | 6.3% |
| 224 | Spinal Neoplasms | 6.3% |
| 225 | Bone Marrow Neoplasms | 6.3% |
| 226 | Appendiceal Neoplasms | 6.2% |
| 227 | Colonic Neoplasms | 6.2% |
| 228 | Rectal Neoplasms | 6.2% |
| 229 | Dysgerminoma | 6.2% |
| 230 | Papilloma | 6.2% |
| 231 | Pseudomyxoma Peritonei | 6.2% |
| 232 | Seminoma | 6.2% |
| 233 | Papillomatosis | 6.2% |
| 234 | Adenomatosis, Pulmonary | 6.2% |
| 235 | Adenomatous Polyps | 6.2% |
| 236 | Cervical Intraepithelial Neoplasia | 6.2% |
| 237 | Leukoplakia, Oral | 6.2% |
| 238 | Paraneoplastic Cerebellar Degeneration | 6.1% |
| 239 | Neuroendocrine Tumors | 6.1% |
| 240 | Lymphangioleiomyomatosis | 6.1% |
| 241 | Cystic Fibrosis | 6% |
| 242 | Fibrosarcoma | 6% |
| 243 | Osteosarcoma | 6% |
| 244 | Hodgkin Disease | 5.9% |
| 245 | Lymphoma, Non-Hodgkin | 5.9% |
| 246 | Congenital Hyperinsulinism | 5.9% |
| 247 | Glioblastoma | 5.7% |
| 248 | Neuroblastoma | 5.7% |
| 249 | Glioblastoma Multiforme | 5.7% |
| 250 | Sarcoma 180 | 5.7% |
| 251 | Nelson Syndrome | 5.7% |
| 252 | Limbic Encephalitis | 5.6% |
| 253 | Anus Neoplasms | 5.5% |
| 254 | Sigmoid Neoplasms | 5.5% |
| 255 | Primary amyloidosis | 5.4% |
| 256 | Nose Neoplasms | 5.4% |
| 257 | Malignant Fibrous Histiocytoma | 5.3% |
| 258 | Lambert-Eaton Myasthenic Syndrome | 5.3% |
| 259 | Mesenteric vascular insufficiency | 5.2% |
| 260 | Esophageal Atresia | 5.2% |
| 261 | Intestinal Atresia | 5.2% |
| 262 | Mesenteric Vascular Occlusion | 5.2% |
| 263 | Intestinal Fistula | 5.2% |
| 264 | Enterocutaneous Fistula | 5.2% |
| 265 | Opsoclonus-Myoclonus Syndrome | 4.9% |
| 266 | Biliary cirrhosis | 4.8% |
| 267 | Pancreatitis, Chronic | 4.8% |
| 268 | Hydatidiform Mole | 4.8% |
| 269 | Carcinoma | 4.7% |
| 270 | Epithelioma | 4.7% |
| 271 | Palatal Neoplasms | 4.7% |
| 272 | Ganglioneuroblastoma | 4.7% |
| 273 | Neurofibrosarcoma | 4.6% |
| 274 | Denys-Drash Syndrome | 4.6% |
| 275 | Waldenstrom Macroglobulinemia | 4.6% |
| 276 | Multiple Myeloma | 4.6% |
| 277 | Rhabdomyosarcoma | 4.6% |
| 278 | Giant Cell Tumor of Bone | 4.6% |
| 279 | Myelitis, Transverse | 4.5% |
| 280 | Proctocolitis | 4.5% |
| 281 | Vipoma | 4.3% |
| 282 | Dysentery | 4.3% |
| 283 | Enteritis | 4.3% |
| 284 | Enterocolitis | 4.3% |
| 285 | Esophageal and Gastric Varices | 4.3% |
| 286 | Esophagitis | 4.3% |
| 287 | Gastritis | 4.3% |
| 288 | Inflammatory Bowel Diseases | 4.3% |
| 289 | Cholecystolithiasis | 4.3% |
| 290 | Pancreatitis, Alcoholic | 4.3% |
| 291 | Phyllodes Tumor | 4.2% |
| 292 | Hemangioendothelioma | 4.2% |
| 293 | Lipoma | 4.2% |
| 294 | Myoma | 4.2% |
| 295 | Myxoma | 4.2% |
| 296 | Neuroma | 4.2% |
| 297 | Angiolipoma | 4.2% |
| 298 | Myelolipoma | 4.2% |
| 299 | Neoplasms, Bone Tissue | 4.2% |
| 300 | Neoplasms, Fibrous Tissue | 4.2% |
| 301 | Smooth Muscle Tumor | 4.2% |
| 302 | Desmoplastic Small Round Cell Tumor | 4.2% |
| 303 | Chondroma | 4.2% |
| 304 | Enchondroma | 4.2% |
| 305 | Meningeal Neoplasms | 4.1% |
| 306 | Rectal Fistula | 4.1% |
| 307 | Anal Fistula | 4.1% |
| 308 | Bile Duct Diseases | 4% |
| 309 | Cholelithiasis | 4% |
| 310 | Chylous Ascites | 4% |
| 311 | Esophageal Diseases | 4% |
| 312 | Fatty Liver | 4% |
| 313 | Gastroenteritis | 4% |
| 314 | Hepatitis | 4% |
| 315 | Portal Hypertension | 4% |
| 316 | Intestinal Diseases | 4% |
| 317 | Liver Cirrhosis | 4% |
| 318 | Pneumoperitoneum | 4% |
| 319 | Stomach Diseases | 4% |
| 320 | Focal Nodular Hyperplasia | 4% |
| 321 | Hepatic Insufficiency | 4% |
| 322 | Steatohepatitis | 4% |
| 323 | Dermatofibrosarcoma | 3.9% |
| 324 | Dermatofibrosarcoma Protuberans | 3.9% |
| 325 | Fatty Liver, Alcoholic | 3.9% |
| 326 | Hepatitis, Alcoholic | 3.9% |
| 327 | Liver Cirrhosis, Alcoholic | 3.9% |
| 328 | Duodenitis | 3.8% |
| 329 | Ileitis | 3.8% |
| 330 | Erosive Duodenitis | 3.8% |
| 331 | Xeroderma Pigmentosum | 3.8% |
| 332 | Ear Neoplasms | 3.8% |
| 333 | Eyelid Neoplasms | 3.8% |
| 334 | Lung Neoplasms | 3.8% |
| 335 | Pleural Neoplasms | 3.8% |
| 336 | Leukemia, Myelomonocytic, Chronic | 3.7% |
| 337 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 3.7% |
| 338 | Brain Neoplasms | 3.7% |
| 339 | Salivary Gland Neoplasms | 3.7% |
| 340 | Spinal Cord Neoplasms | 3.7% |
| 341 | Tongue Neoplasms | 3.7% |
| 342 | Adrenal Gland Diseases | 3.7% |
| 343 | Gonadal Disorders | 3.7% |
| 344 | Pancreatic Diseases | 3.7% |
| 345 | Parathyroid Diseases | 3.7% |
| 346 | Thyroid Diseases | 3.7% |
| 347 | Liver Diseases, Parasitic | 3.7% |
| 348 | Polycystic Ovary Syndrome | 3.7% |
| 349 | Uterine Neoplasms | 3.7% |
| 350 | Vaginal Neoplasms | 3.7% |
| 351 | Vulvar Neoplasms | 3.7% |
| 352 | Uterine Cancer | 3.7% |
| 353 | Fallopian Tube Neoplasms | 3.7% |
| 354 | Hepatic Veno-Occlusive Disease | 3.6% |
| 355 | Peliosis Hepatis | 3.6% |
| 356 | Hepatopulmonary Syndrome | 3.6% |
| 357 | Anus, Imperforate | 3.6% |
| 358 | Gastrointestinal Hemorrhage | 3.6% |
| 359 | Hemoperitoneum | 3.6% |
| 360 | Hepatomegaly | 3.6% |
| 361 | Mesenteric Panniculitis | 3.6% |
| 362 | Panniculitis, Peritoneal | 3.6% |
| 363 | Peritonitis | 3.6% |
| 364 | Peritoneal Fibrosis | 3.6% |
| 365 | Encapsulating Peritoneal Sclerosis | 3.6% |
| 366 | Anorectal Malformations | 3.6% |
| 367 | Biliary Fistula | 3.6% |
| 368 | Gastric Fistula | 3.6% |
| 369 | Hepatic Vein Thrombosis | 3.6% |
| 370 | Liver Abscess | 3.6% |
| 371 | Budd-Chiari Syndrome | 3.6% |
| 372 | Tuberculosis, Gastrointestinal | 3.6% |
| 373 | Colitis | 3.6% |
| 374 | Duodenogastric Reflux | 3.6% |
| 375 | Peptic Ulcer | 3.6% |
| 376 | Proctitis | 3.6% |
| 377 | Choledocholithiasis | 3.6% |
| 378 | Nesidioblastosis | 3.5% |
| 379 | Pharyngeal Neoplasms | 3.4% |
| 380 | Mastocytosis | 3.4% |
| 381 | Sturge-Weber Syndrome | 3.4% |
| 382 | Central Nervous System Cysts | 3.4% |
| 383 | Lymphatic Metastasis | 3.4% |
| 384 | Neoplasms, Unknown Primary | 3.4% |
| 385 | Leukemic Infiltration | 3.4% |
| 386 | Neoplasm Micrometastasis | 3.4% |
| 387 | Penile Neoplasms | 3.4% |
| 388 | Prostatic Neoplasms | 3.4% |
| 389 | Hemangioma, Cavernous | 3.4% |
| 390 | Leukemia, T-Cell | 3.4% |
| 391 | Leukemia, B-Cell | 3.4% |
| 392 | neurofibroma | 3.4% |
| 393 | Lymphoma, Follicular | 3.3% |
| 394 | T-Cell Lymphoma | 3.3% |
| 395 | Mantle cell lymphoma | 3.3% |
| 396 | Polycythemia Vera | 3.3% |
| 397 | Bone Diseases, Endocrine | 3.3% |
| 398 | Chemical and Drug Induced Liver Injury | 3.3% |
| 399 | Diabetes Mellitus | 3.3% |
| 400 | Pituitary Diseases | 3.3% |
| 401 | Liver Abscess, Amebic | 3.2% |
| 402 | Hepatorenal Syndrome | 3.2% |
| 403 | Appendicitis | 3.2% |
| 404 | Alveolar rhabdomyosarcoma | 3.2% |
| 405 | Laryngeal neoplasm | 3.2% |
| 406 | Bladder Neoplasm | 3.1% |
| 407 | Kidney Neoplasm | 3.1% |
| 408 | Ureteral Neoplasms | 3.1% |
| 409 | Urethral Neoplasms | 3.1% |
| 410 | Dwarfism | 3% |
| 411 | Porphyrias, Hepatic | 3% |
| 412 | Pouchitis | 2.9% |
| 413 | Crohn Disease | 2.8% |
| 414 | Duodenal Obstruction | 2.8% |
| 415 | Enterocolitis, Neutropenic | 2.8% |
| 416 | Necrotizing Enterocolitis | 2.8% |
| 417 | Adenocarcinoma | 2.7% |
| 418 | Meningeal Carcinomatosis | 2.7% |
| 419 | fibroma | 2.6% |
| 420 | Fibromatosis | 2.6% |
| 421 | Osteoblastoma | 2.6% |
| 422 | Osteoma | 2.6% |
| 423 | Rhabdomyoma | 2.6% |
| 424 | Chondromatosis | 2.6% |
| 425 | Hemangioblastoma | 2.6% |
| 426 | Lymphoma, Extranodal NK-T-Cell | 2.6% |
| 427 | Enterocolitis, Pseudomembranous | 2.6% |
| 428 | pseudomembranous colitis | 2.6% |
| 429 | Dysentery, Bacillary | 2.6% |
| 430 | Duodenal Ulcer | 2.5% |
| 431 | Peptic Ulcer Perforation | 2.5% |
| 432 | Gastric ulcer | 2.5% |
| 433 | Bronchial Neoplasms | 2.4% |
| 434 | Multiple Pulmonary Nodules | 2.4% |
| 435 | Cecal Diseases | 2.4% |
| 436 | Cholangitis | 2.4% |
| 437 | Cholecystitis | 2.4% |
| 438 | Cholestasis | 2.4% |
| 439 | Colonic Diseases | 2.4% |
| 440 | Common Bile Duct Diseases | 2.4% |
| 441 | Esophageal Stenosis | 2.4% |
| 442 | Hepatitis, Chronic | 2.4% |
| 443 | Ileal Diseases | 2.4% |
| 444 | Intestinal Obstruction | 2.4% |
| 445 | Intestinal Perforation | 2.4% |
| 446 | Jejunal Diseases | 2.4% |
| 447 | Pneumatosis Cystoides Intestinalis | 2.4% |
| 448 | Rectal Diseases | 2.4% |
| 449 | Gastric Dilatation | 2.4% |
| 450 | Liver Failure | 2.4% |
| 451 | Gastric outlet obstruction | 2.4% |
| 452 | Cronkhite-Canada Syndrome | 2.4% |
| 453 | Non-alcoholic Fatty Liver Disease | 2.4% |
| 454 | Chronic active hepatitis | 2.4% |
| 455 | Intestinal Polyposis | 2.4% |
| 456 | Supratentorial Neoplasms | 2.4% |
| 457 | Endometrial Neoplasms | 2.4% |
| 458 | Mastocytoma | 2.3% |
| 459 | Mastocytosis, Systemic | 2.3% |
| 460 | Leukemia, Myeloid, Chronic-Phase | 2.3% |
| 461 | Colitis, Ischemic | 2.3% |
| 462 | Hypopharyngeal Neoplasms | 2.2% |
| 463 | Pleural Effusion, Malignant | 2.2% |
| 464 | Hypopharyngeal Cancer | 2.2% |
| 465 | Esophageal Perforation | 2.2% |
| 466 | Hepatitis, Animal | 2.2% |
| 467 | Hepatitis, Viral, Human | 2.2% |
| 468 | Intestinal Diseases, Parasitic | 2.2% |
| 469 | Parotid Neoplasms | 2.2% |
| 470 | Prostatic Neoplasms, Castration-Resistant | 2.2% |
| 471 | Congenital Hypothyroidism | 2.2% |
| 472 | Deglutition Disorders | 2.2% |
| 473 | Achlorhydria | 2.1% |
| 474 | Liver Cirrhosis, Experimental | 2.1% |
| 475 | Gastric Antral Vascular Ectasia | 2.1% |
| 476 | Peptic Ulcer Hemorrhage | 2.1% |
| 477 | Gastroparesis | 2.1% |
| 478 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 479 | Leukemia, Large Granular Lymphocytic | 2.1% |
| 480 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.1% |
| 481 | Lymphoma, T-Cell, Cutaneous | 2.1% |
| 482 | Lymphoma, AIDS-Related | 2.1% |
| 483 | Enteropathy-Associated T-Cell Lymphoma | 2.1% |
| 484 | Primary Effusion Lymphoma | 2.1% |
| 485 | Hepatitis B, Chronic | 2% |
| 486 | Hepatitis C, Chronic | 2% |
| 487 | Adrenal Cortex Diseases | 2% |
| 488 | Euthyroid Sick Syndromes | 2% |
| 489 | Goiter | 2% |
| 490 | Hyperparathyroidism | 2% |
| 491 | Hyperthyroidism | 2% |
| 492 | Hyperthyroxinemia | 2% |
| 493 | Hypogonadism | 2% |
| 494 | Hypoparathyroidism | 2% |
| 495 | Hypothyroidism | 2% |
| 496 | Delayed Puberty | 2% |
| 497 | Precocious Puberty | 2% |
| 498 | Thyroiditis | 2% |
| 499 | Hypogonadotropic hypogonadism | 2% |
| 500 | Testotoxicosis | 2% |
| 501 | Secondary hypothyroidism | 2% |
| 502 | Primary Hyperthyroidism | 2% |
| 503 | Primary Hypothyroidism | 2% |
| 504 | Fascioliasis | 2% |
| 505 | Colonic Pseudo-Obstruction | 1.9% |
| 506 | Echinococcosis, Hepatic | 1.9% |
| 507 | Melena | 1.9% |
| 508 | Chemical and Drug Induced Liver Injury, Chronic | 1.9% |
| 509 | Reye Syndrome | 1.9% |
| 510 | Hematemesis | 1.9% |
| 511 | Zellweger Syndrome | 1.9% |
| 512 | Nasopharyngeal Neoplasms | 1.9% |
| 513 | Testicular Diseases | 1.8% |
| 514 | Hepatolenticular Degeneration | 1.8% |
| 515 | Ovarian Diseases | 1.8% |
| 516 | Empty Sella Syndrome | 1.8% |
| 517 | Hyperpituitarism | 1.8% |
| 518 | Hypopituitarism | 1.8% |
| 519 | Hypophysitis | 1.8% |
| 520 | Fibromatosis, Aggressive | 1.8% |
| 521 | Fibromatosis, Abdominal | 1.8% |
| 522 | Graves Disease | 1.8% |
| 523 | Cell Transformation, Viral | 1.8% |
| 524 | Variegate Porphyria | 1.8% |
| 525 | Acute intermittent porphyria | 1.8% |
| 526 | Porphyria Cutanea Tarda | 1.8% |
| 527 | Brain Stem Neoplasms | 1.8% |
| 528 | Paranasal Sinus Neoplasms | 1.7% |
| 529 | Burkitt Lymphoma | 1.7% |
| 530 | Gestational Diabetes | 1.6% |
| 531 | Latent Autoimmune Diabetes in Adults | 1.6% |
| 532 | Diabetes Insipidus | 1.6% |
| 533 | Diabetes Mellitus, Experimental | 1.6% |
| 534 | Tonsillar Neoplasms | 1.6% |
| 535 | Cholestasis, Extrahepatic | 1.6% |
| 536 | Biliary Dyskinesia | 1.6% |
| 537 | Cholangitis, Sclerosing | 1.6% |
| 538 | Colonic Diseases, Functional | 1.6% |
| 539 | Esophageal motility disorders | 1.6% |
| 540 | Fecal Incontinence | 1.6% |
| 541 | Fecal Impaction | 1.6% |
| 542 | Intussusception | 1.6% |
| 543 | Mallory-Weiss Syndrome | 1.6% |
| 544 | Megacolon | 1.6% |
| 545 | Pyloric Stenosis | 1.6% |
| 546 | Liver Failure, Acute | 1.6% |
| 547 | Acalculous Cholecystitis | 1.6% |
| 548 | End Stage Liver Disease | 1.6% |
| 549 | Ileus | 1.6% |
| 550 | Meconium ileus | 1.6% |
| 551 | Cerebellar Neoplasms | 1.6% |
| 552 | Hermaphroditism | 1.5% |
| 553 | Disorders of Sex Development | 1.5% |
| 554 | Pituitary Apoplexy | 1.5% |
| 555 | Dupuytren Contracture | 1.5% |
| 556 | Urticaria Pigmentosa | 1.4% |
| 557 | Hemorrhoids | 1.4% |
| 558 | Autoimmune hepatitis | 1.4% |
| 559 | Choroid Plexus Papilloma | 1.4% |
| 560 | Mycosis Fungoides | 1.4% |
| 561 | Lymphomatoid Papulosis | 1.4% |
| 562 | Plasmablastic lymphoma | 1.4% |
| 563 | Afferent Loop Syndrome | 1.4% |
| 564 | Celiac Disease | 1.4% |
| 565 | Short Bowel Syndrome | 1.4% |
| 566 | Sprue, Tropical | 1.4% |
| 567 | Steatorrhea | 1.4% |
| 568 | Rectocele | 1.4% |
| 569 | Sprue | 1.4% |
| 570 | Diverticulitis | 1.4% |
| 571 | Dumping Syndrome | 1.4% |
| 572 | Rectal Prolapse | 1.4% |
| 573 | Hepatitis, Viral, Animal | 1.3% |
| 574 | Giardiasis | 1.3% |
| 575 | Hepatitis E | 1.3% |
| 576 | Hepatitis B | 1.3% |
| 577 | Hepatitis C | 1.3% |
| 578 | Diverticulum | 1.3% |
| 579 | Hepatitis A | 1.3% |
| 580 | Diverticulosis | 1.3% |
| 581 | Hepatic Encephalopathy | 1.3% |
| 582 | Maxillary Sinus Neoplasms | 1.3% |
| 583 | Kallmann Syndrome | 1.2% |
| 584 | Cushing Syndrome | 1.2% |
| 585 | Hyperaldosteronism | 1.2% |
| 586 | Hyperparathyroidism, Secondary | 1.2% |
| 587 | Hypoaldosteronism | 1.2% |
| 588 | Thyrotoxicosis | 1.2% |
| 589 | Hyperparathyroidism, Primary | 1.2% |
| 590 | Thyroid Hormone Resistance Syndrome | 1.2% |
| 591 | Sezary Syndrome | 1.2% |
| 592 | Massive Hepatic Necrosis | 1.2% |
| 593 | Esophageal Achalasia | 1.2% |
| 594 | Anal Fissure | 1.2% |
| 595 | Intestinal Pseudo-Obstruction | 1.2% |
| 596 | Irritable Bowel Syndrome | 1.2% |
| 597 | Superior Mesenteric Artery Syndrome | 1.2% |
| 598 | Emphysematous Cholecystitis | 1.2% |
| 599 | Neurogenic Bowel | 1.2% |
| 600 | Sphincter of Oddi Dysfunction | 1.2% |
| 601 | Anal Ulcer | 1.2% |
| 602 | Lactose Intolerance | 1.2% |
| 603 | Diabetic Foot | 1.2% |
| 604 | Klinefelter Syndrome | 1.1% |
| 605 | Addison Disease | 1.1% |
| 606 | Diabetic Angiopathies | 1.1% |
| 607 | Autoimmune thyroiditis | 1.1% |
| 608 | Primary Adrenal Insufficiency | 1.1% |
| 609 | Diabetic Neuropathies | 1.1% |
| 610 | Myxedema | 1.1% |
| 611 | Orchitis | 1.1% |
| 612 | Diabetic Amyotrophy | 1.1% |
| 613 | Diabetic Autonomic Neuropathy | 1.1% |
| 614 | Diabetic Cardiomyopathies | 1.1% |
| 615 | Pruritus Ani | 1.1% |
| 616 | Ovarian Hyperstimulation Syndrome | 1.1% |
| 617 | Hyperprolactinemia | 1.1% |
| 618 | Cryptosporidiosis | 1% |
| 619 | Gigantism | 1% |
| 620 | Diabetic Nephropathy | 1% |
| 621 | Acromegaly | 1% |
| 622 | Anovulation | 1% |
| 623 | Diabetic Ketoacidosis | 1% |
| 624 | Oophoritis | 1% |
| 625 | Laryngopharyngeal Reflux | 0.9% |
| 626 | Cryptorchidism | 0.9% |
| 627 | Gonadal Dysgenesis | 0.9% |
| 628 | Adrenogenital Syndrome | 0.9% |
| 629 | Ovotesticular Disorders of Sex Development | 0.9% |
| 630 | Hyperandrogenism | 0.9% |
| 631 | Hyperglycemic Hyperosmolar Nonketotic Coma | 0.8% |
| 632 | Hashimoto Disease | 0.8% |
| 633 | Rift Valley Fever | 0.8% |
| 634 | CREST Syndrome | 0.7% |
| 635 | Radicular Cyst | 0.7% |
| 636 | Diabetic Retinopathy | 0.6% |
| 637 | Turner Syndrome | 0.6% |
| 638 | Waterhouse-Friderichsen Syndrome | 0.6% |
| 639 | Renal Osteodystrophy | 0.5% |
| 640 | Renal rickets | 0.5% |
| 641 | Adrenoleukodystrophy | 0.4% |
